TSHA is currently covered by 11 analysts with average potential upside of $14.29 (213.62%) backed by 5 price targets and 28 ratings. Documented since 19-Oct-2020. Analyst's average stock valuation to be materialised ratio is 4.76% with an average time for price targets to be met of 13.14 days.
Most recent stock forecast was given by YUN ZHONG from BTIG on 02-Feb-2023.
Highest price target for TSHA is 26, Lowest price target is 1, average price target is 13.5.
Currently, out of the existing stock ratings of TSHA - 24 which are a Buy (96%), 1 which are a Hold (4%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
25
1 months 23 days ago
0/2 (0%)
$18.47 (182.70%)
Buy
4
$3.32 (488.24%)
36
1 months 24 days ago
0/7 (0%)
$23.57 (285.45%)
Buy
6
$5.32 (782.35%)
1 months 24 days ago
0/1 (0%)
$4.79 (395.87%)
Buy
6
$5.32 (782.35%)
1 months 24 days ago
0/1 (0%)
$4.79 (395.87%)
Hold
3
$2.32 (341.18%)
4 months 16 days ago
1/3 (33.33%)
$7.81 (52.75%)
92
What is TSHA(Taysha Gene Therapies Inc.) average time for price targets to be met?
Which analyst has the current highest performing score on TSHA(Taysha Gene Therapies Inc.) with a proven track record?
